NCT01398592 - Vildagliptin Versus Sitagliptin - Differences in Fasting Plasma Glucose Lowering Efficacy | Biotech Hunter

Enrollment

187

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG

Vildagliptin

50mg vildagliptin bid

DRUG

Sitagliptin

100mg sitagliptin po qd

Trial Locations (15)

12347

Novartis Investigative Site, Berlin

13597

Novartis Investigative Site, Berlin

14089

Novartis Investigative Site, Berlin

14469

Novartis Investigative Site, Potsdam

29221

Novartis Investigative Site, Celle

30165

Novartis Investigative Site, Hanover

30167

Novartis Investigative Site, Hanover

31275

Novartis Investigative Site, Lehrte

32549

Novartis Investigative Site, Bad Oeynhausen

34117

Novartis Investigative Site, Kassel

35274

Novartis Investigative Site, Kirchhain

45468

Novartis Investigative Site, Mülheim

46049

Novartis Investigative Site, Oberhausen

49080

Novartis Investigative Site, Osnabrück

70378

Novartis Investigative Site, Stuttgart